We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antibody Panel Predicts Risk of Organ Loss Prior to Kidney Transplantation

By LabMedica International staff writers
Posted on 21 Oct 2014
Print article
Image: High magnification micrograph of focal segmental glomerulosclerosis (FSGS) (Photo courtesy of Wikimedia Commons).
Image: High magnification micrograph of focal segmental glomerulosclerosis (FSGS) (Photo courtesy of Wikimedia Commons).
An ELISA test based on a panel of seven antibodies can help identify primary focal segmental glomerulosclerosis (FSGS) patients at high risk of recurrence before kidney transplantation.

Recurrence of FSGS after kidney transplantation is a cause of accelerated graft loss. Recurrence is managed by immunosuppressive drugs along with current standards of treatment that include salt restriction, diuretics and steroids, plasma filtration, and immunoadsorption.

To identify biomarkers for risk of recurring FSGS prior to kidney transplantation, investigators at the University of California, San Francisco (USA) and Rush University Medical Center (Chicago, IL, USA) processed 141 serum samples from 64 patients with and without primary recurring FSGS and 34 non-FSGS control patients transplanted at four hospitals. They screened about 9,000 antigens in pre-transplant sera and selected 10 antibodies targeting glomerular antigens for enzyme-linked immunosorbent assay (ELISA) validation.

Results revealed that a panel of seven antibodies (CD40, PTPRO, CGB5, FAS, P2RY11, SNRPB2, and APOL2) could predict post-transplant FSGS recurrence with 92% accuracy. Pre-transplant elevation of anti-CD40 antibody alone had the best correlation (78% accuracy) with recurring FSGS risk after transplantation.

The CD40 protein is a member of the TNF-receptor superfamily. This receptor has been found to be essential in mediating a broad variety of immune and inflammatory responses including T-cell-dependent immunoglobulin class switching, memory B- cell development, and germinal center formation. Epitope mapping of CD40 with customized peptide arrays and recurring FSGS sera demonstrated altered immunogenicity of the extracellular CD40 domain in recurring FSGS patients. Immunohistochemistry of CD40 demonstrated a differential expression in FSGS compared to non-FSGS controls.

“This is a new blood test to monitor patients before kidney transplant and predict who may have recurrence of FSGS, thereby preventing loss of kidneys,” said senior author Dr. Minnie M. Sarwal, professor of transplant surgery at the University of California, San Francisco. “We want to predict FSGS recurrence before we put a kidney in. We then can treat the high-risk patients with a new drug to possibly prevent disease.”

Related Links:

University of California, San Francisco
Rush University Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.